Business Segments · Revenue
Diagnostics — Revenue
Labcorp Holdings Diagnostics — Revenue increased by 1.2% to $2.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $2.63B to $2.76B. Over 4 years (FY 2021 to FY 2025), Diagnostics — Revenue shows relatively stable performance with a 1.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Growth in revenue signals increased testing volume or successful price realization, while declining revenue suggests market share loss or pricing pressure.
Detailed definition
This represents the total gross income generated by the diagnostics segment from providing laboratory testing and relate...
Peer comparison
Core performance metric for all clinical laboratory and diagnostic service providers.
Metric ID:
lh_segment_diagnostics_revenuesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.59B | $2.59B | $2.59B | $2.45B | $2.26B | $2.21B | $2.29B | $2.38B | $2.34B | $2.34B | $2.35B | $2.48B | $2.52B | $2.55B | $2.59B | $2.63B | $2.75B | $2.77B | $2.73B | $2.76B |
| QoQ Change | — | +0.0% | +0.0% | -5.3% | -8.1% | -2.1% | +3.6% | +4.2% | -1.8% | +0.2% | +0.1% | +5.7% | +1.8% | +1.1% | +1.3% | +1.7% | +4.5% | +0.8% | -1.5% | +1.2% |
| YoY Change | — | — | — | — | -12.9% | -14.8% | -11.8% | -2.9% | +3.8% | +6.2% | +2.6% | +4.1% | +7.9% | +8.9% | +10.2% | +6.0% | +8.9% | +8.5% | +5.5% | +5.0% |
Range$2.21B – $2.77B
CAGR+1.4%
Avg YoY Growth+2.2%
Median YoY Growth+5.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's diagnostics — revenue?
- Labcorp Holdings (LH) reported diagnostics — revenue of $2.76B in Q1 2026.
- How has Labcorp Holdings's diagnostics — revenue changed year-over-year?
- Labcorp Holdings's diagnostics — revenue increased by 5.0% year-over-year, from $2.63B to $2.76B.
- What is the long-term trend for Labcorp Holdings's diagnostics — revenue?
- Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — revenue has grown at a 1.2% compound annual growth rate (CAGR), from $10.36B to $10.88B.
- What does diagnostics — revenue mean?
- Total sales generated by the diagnostics business segment.